(Circulation. 2000;102:1400.)
© 2000 American Heart Association, Inc.
Clinical Investigation and Reports |
From the Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, Minn.
| Abstract |
|---|
|
|
|---|
Methods and ResultsIn a prospective study of 21 control subjects and 128 patients with LVD (defined as ejection fraction <50%, mean 31±9%) in sinus rhythm, we quantified simultaneously by echocardiography the effective regurgitant orifice (ERO) of FMR by using 2 methods: mitral deformation (valve and annulus) and left ventricular (LV) global (volumes, stress, function, and sphericity) and local (papillary muscle displacements and regional wall motion index) remodeling. A wide range of ERO (15±14 mm2, 0 to 87 mm2) was observed, unrelated to ejection fraction (P=0.32). The major determinant of ERO was mitral deformation, ie, systolic valvular tenting and annular contraction in univariate (r=0.74 and r=-0.61, respectively; both P<0.0001) and multivariate (both P<0.0001) analyses, independent of global LV remodeling. Systolic valvular tenting was strongly determined by local LV alterations, particularly apical (r=0.75) and posterior (r=0.70) displacement of papillary muscle, with confirmation in multivariate analysis (both P<0.0001), independent of LV volumes, function, and sphericity.
ConclusionsThe presence and degree of FMR complicating LVD are unrelated to the severity of LVD. Local LV remodeling (apical and posterior displacement of papillary muscles) leads to excess valvular tenting independent of global LV remodeling. In turn, excess tenting and loss of systolic annular contraction are associated with larger EROs. These determinants of FMR warrant consideration for specific approaches to the treatment of FMR complicating LVD.
Key Words: echocardiography heart failure ventricles mitral valve regurgitation
| Introduction |
|---|
|
|
|---|
Although incomplete closure of normal leaflets is the immediate cause of FMR,6 10 the link between LV remodeling and the degree of FMR is not well defined. In experimental in vivo studies, FMR has been attributed to global LV dilatation11 or sphericity.12 More recently, in vitro13 and animal7 8 studies have suggested that complex alterations of spatial relationships between LV and the mitral apparatus may induce severe FMR. In humans, LV sphericalization has been proposed as a potential mechanism of FMR,14 15 but this phenomenon is frequent in LV enlargement with or without regurgitation.16 Similarly, the influence of mitral annulus enlargement on FMR has been disputed.9 These uncertainties are related to the limitations of angiographic17 or color Doppler18 grading of mitral regurgitation (MR) and to the complexity of simultaneous quantification of MR, of mitral deformation, and of global and local LV remodeling. Nevertheless, such an analysis is essential because FMR is a major target of medical19 and surgical treatment.20
Recent advances in noninvasive Doppler echocardiography allow reliable assessment of regurgitant volume11 12 13 and of the orifice21 22 of MR by combined methods. Quantification of mitral deformation10 and LV remodeling14 15 can be obtained simultaneously. Therefore, we undertook a prospective quantitative study of patients with LVD, with the hypothesis that the effective regurgitant orifice (ERO) of FMR is directly determined by the degree of functional mitral deformation, which in turn is independently associated with local rather than global LV remodeling.
| Methods |
|---|
|
|
|---|
Patients were prospectively enrolled. Inclusion criteria were (1) systolic LVD; (2) structurally normal cardiac valves; (3) measurement of aortic, mitral, and LV stroke volumes allowing calculation of MR volume and ERO; (4) anatomic analysis with quantification of LV remodeling and mitral apparatus deformation; and (5) sinus rhythm.
Exclusion criteria were (1) clinical or echocardiographic evidence of other cardiac diseases, such as organic valvular, pericardial, congenital, or infiltrative heart disease; (2) structural mitral lesions, such as valve prolapse or rheumatic disease; (3) more than trace aortic regurgitation; (4) right ventricular alterations resulting in abnormal position or movement of the septum; (5) acute myocardial infarction; (6) suboptimal echocardiographic windows, leading to incomplete quantification of FMR or anatomic assessment; and (7) atrial fibrillation or flutter.
In addition, 21 subjects with normal Doppler echocardiography were included as a control group for quantitative methods of MR and LV remodeling.
Echocardiographic Measurements
Global LV Remodeling
LV end-diastolic and end-systolic volume
indexes (EDVI and ESVI, respectively) and EF were measured by the
biapical Simpson disk method.14 LV length and width were
measured, and a dimensionless sphericity index (ratio of length to
width) was calculated at end systole and end
diastole.15 End-systolic wall stress
was calculated16 by using blood pressure
measurements.23
Quantification of MR
Two simultaneous methods were used: (1) quantitative
Doppler using mitral and aortic stroke volumes11 13
and (2) quantitative 2D echocardiography using LV
and aortic stroke volumes.12 13 These methods were
averaged, allowing calculation of regurgitant volume (RVol),
regurgitant fraction (RF), and ERO.21 In 75 patients, the
proximal isovelocity surface area method22 was also used.
In patients with no or trivial FMR by color Doppler, RVol and RF
were used as calculated, and ERO was assumed as null. Also, jet area
and jet/left atrial area ratio were measured.
Mitral Deformation
Mitral annular diameter was measured in apical long-axis,
4-chamber, and 2-chamber views at end diastole and end
systole, and annular areas and contraction were calculated.
Systolic leaflet deformation, defined as valvular
tenting area, was measured by the area enclosed between the annular
plane and mitral leaflets from the parasternal long-axis view
(Figure 1
) at early and late
systole. The distance between leaflet coaptation and the mitral annulus
plane at early and end systole measured displacement of mitral
coaptation toward the LV apex.10 24
|
Local LV Remodeling
Asynergy of the LV wall at the papillary muscle attachment was
measured as the wall motion score index for the corresponding 8 LV
segments.14 The displacement of papillary muscle was
quantified as distances from well-defined anatomic landmarks at early
and end systole. From the parasternal short-axis view, the geometric
chord defined by the septal insertions and the mid septal perpendicular
line were used as references. Lateral and inferior
displacements of anterior and posterior papillary muscles were measured
as distances from these fixed references. Separation between papillary
muscles was directly measured. By use of the long-axis view (Figure 2
), apical displacement of the posterior
papillary muscle was measured as the distance between the papillary
muscle head and the fixed intervalvular fibrosa
(annular-papillary distance).
|
Statistical Analysis
Data are expressed as mean±SD or percentages. Group comparisons
used ANOVA, Students t test, or
2
test. For presentation purposes, independent variables
were stratified according to ERO level, and their
univariate correlations with ERO were summarized. To
analyze independent determinants of the degree of FMR,
multivariate analysis based on stepwise
multiple linear regression (with the ERO and RF as dependent
variables and variables measuring mitral deformation as
independent variables) was performed. Variables assessing local
LV remodeling and then those measuring global LV remodeling were added
to the models. A similar multivariate analysis
was performed with mitral valvular tenting as a dependent
variable and variables measuring local and global LV remodeling
as independent variables. The entry criterion in the
multivariate analysis was a
univariate P<0.10. In 15 patients, a second
observer measured the variables of local LV remodeling and
mitral deformation to assess interobserver variability. A value of
P<0.05 was considered significant.
| Results |
|---|
|
|
|---|
Compared with 21 controls, patients with LVD showed no
differences in age, sex, or body surface area but significant
differences in global and local LV remodeling and mitral deformation
(Tables 1
and 2
, respectively). The anatomic
measurements tended to decrease from early to late systole in patients
with LVD (eg, mitral tenting 7.5±1.6 to 6.5±1.4
cm2) and in normal controls (eg, mitral tenting
4.4±0.8 to 3.8±0.6 cm2) (all
P<0.05). However, the magnitude of change was not different
between patients and controls (all P>0.10) despite
differences in baseline deformation. Because early systolic
measurements showed the best correlations with FMR, these values were
displayed (Tables 1
and 2
).
|
|
Determinants of Degree of FMR
Patients with LVD were divided into 4 groups according to ERO: no
MR (ERO 0, n=21), ERO <10 mm2 (n=26), ERO
10 to <20 mm2 (n=37), and ERO
20
mm2 (n=44). These groups also showed significant
differences in RVol (3.9±2.7, 11±5, 21±6, and 39±17 mL,
respectively; P<0.0001), RF (4.7±3%, 16±6%, 27±7%,
and 41±10%; P<0.0001), jet area (0.5±1, 5±3, 7±3, and
13±6 cm2; P<0.0001), and jet/left
atrial area ratio (1.9±4%, 13±13%, 26±9%, and 39±11%;
P<0.0001).
Comparison between groups (and correlations with ERO) are shown in
Table 1
for baseline characteristics and global LV remodeling
and in Table 2
for mitral deformation and local LV remodeling.
Notably, no significant differences between groups and no significant
correlations with ERO were noted for LVEF and wall stress. Higher LV
volumes and lower length/diameter ratios were present with higher
degrees of FMR, and EDVI displayed the strongest correlation with ERO
(r=0.49, P<0.0001; Figure 3
), but the other variables showed
weaker correlations.
|
Mitral deformation increased with higher degrees of FMR. The
strongest correlation with ERO was observed with the systolic
mitral tenting area (r=0.74, P<0.0001; Figure 3
). Larger EROs were also associated with larger mitral annular
areas and decreased annular contraction (r=-0.61,
P<0.0001; Figure 3
).
For local LV remodeling, posterior displacements of both papillary muscles were associated with larger EROs (r=0.65 and 0.50, respectively; both P<0.0001), whereas lateral displacements showed weaker associations. Also, apical displacement of papillary muscle, measured as papillary-fibrosa distance, showed significant association with ERO (r=0.55, P<0.0001).
Multivariate analysis of ERO determinants
(Table 3
) showed the systolic
tenting area to be the most powerful predictor
(R2=0.53 in all models) in association
with annular systolic contraction. Posterior displacement of
both papillary muscles also contributed independently to larger EROs.
The addition of variables of global LV remodeling did not affect
the determinants of ERO. Larger EDVI and lower systolic blood
pressure were weakly associated with larger EROs. These results were
confirmed by direct comparison of correlations with ERO; those using
tenting area and annular contraction were superior to those using EDVI
as an independent variable (P=0.0004 and
P=0.025, respectively).
|
Similar independent determinants were noted for RF (Table 3
) and
the jet/left atrial area ratio, namely, tenting, annular
contractility, and posterior displacement of anterior
papillary muscle.
Comparing patients with and without coronary disease, similar tenting was observed (7.7±1.7 versus 7.1±1.5 cm2, P=0.10), and ANCOVA showed similar regressions between ERO and tenting (P=0.68), ERO and annular contraction (P=0.74), and tenting and apical papillary displacement (P=0.32).
Determinants of Valvular Tenting
Systolic valvular tenting is the major determinant
of FMR due to LVD. Tenting demonstrated strong correlations with apical
papillary muscle displacement (papillary-fibrosa distance,
r=0.75, P<0.0001; Figure 4
) and with posterior displacement of
anterior and posterior papillary muscles (r=0.70 and 0.65,
respectively; both P<0.0001; Figure 4
).
Multivariate analysis showed that tenting was
determined by apical and posterior displacement of papillary muscles
and by wall motion index of the segments supporting the papillary
muscles, independent of global LV remodeling (Table 3
). LV
volumes, function, or sphericity showed nonsignificant or weak
association with tenting (strongest with EDVI, r=0.45;
Figure 4
) and were not independent determinants of tenting.
Direct comparison of correlations with tenting confirmed that those
obtained with papillary muscle displacements were superior to those
obtained with EDVI (both P<0.0001).
|
Quality Control
In 42 patients without regurgitation, calculated
RVol and RF were extremely low (3.7±2.4 mL and 4.4±2.9%,
respectively). Correlations between quantitative Doppler methods
and the proximal isovelocity surface area method were excellent for
RVol (r=0.93, P<0.0001; SEE 6.5 mL) and ERO
(r=0.93, P<0.0001; SEE 5
mm2).
For the 15 patients in whom the mitral and LV remodeling was measured by a second observer, interobserver variability was modest. The correlations between the variables obtained by the 2 observers were as follows: r=0.97, P=0.02, and SEE=0.32 cm2 for systolic mitral tenting; r=0.93, P=0.02, and SEE=0.42 cm for papillary-fibrosa distance; and r=0.91, P=0.06, and SEE=0.57 cm for posterior displacement of papillary muscle.
| Discussion |
|---|
|
|
|---|
Importance of FMR
The clinical significance of FMR is frequently underrated because
of low murmur intensity2 and mismatch between severe
symptoms and unimpressive RVol and ERO.5 22 Nevertheless,
FMR is a major component of LVD, causing pulmonary
hypertension5 and LV volume overload,17 21
which in turn potentiates LV remodeling, a major determinant of the
outcome of LVD. Furthermore, FMR is a marker of poor prognosis in LVD
that is due to cardiomyopathy17 25 or
ischemic disease.20 26
Another hindrance to comprehending the role of FMR in LVD is its sensitivity to loading manipulations.27 Sensitivity to intense treatment19 does not suggest that FMR is insignificant but that FMR is a treatable component of LVD.28 Furthermore, surgical treatment of FMR has been suggested as an important therapeutic option,29 even in cardiomyopathy.30 However, lack of quantitative data on the mechanism of FMR in humans hinders approaches to FMR complicating LVD.
Mechanism of FMR
FMR is not the result of organic mitral lesions but of incomplete
closure of normal leaflets.6 10 LV remodeling precedes LVD
and FMR,31 but similar LVD may be associated with widely
different degrees of FMR. These complex phenomena require a stepwise
analysis, starting with valvular deformations leading
to FMR.
Mitral valvular tenting is present in LVD,10 but tenting degree directly determines ERO of FMR. Tenting is characterized by insufficient systolic leaflet body displacement toward the annulus, with coaptation limited to leaflet tips,32 resulting in MR. Annular alterations have an adjunct role. Considerable annular dilatation would be required to result in inadequate mitral coaptation, because the ratio of leaflets to the annular surface area is >2.32 However, insufficient coaptation due to tenting is increased by the loss of systolic annular function, separating the leaflets further.10 Annular alterations can be palliated by annuloplasty,30 but mechanisms determining excess tenting warrant consideration to repair FMR.
The degree of LV dysfunction or enlargement is not a primary determinant of regurgitation, and previous studies have attributed FMR to LV sphericalization.33 34 However, global sphericalization15 is common in any LV enlargement and has shown poor correlations with ERO.
Recent pioneering studies performed in vitro35 or in animal models of LVD7 8 have suggested that excessive papillary muscle displacement may generate FMR. This displacement induces valve tethering, which is persistent even in diastole. The present study of humans with a wide range of LVD and FMR shows that apical and posterior displacements of the papillary muscle are the main determinants of tenting and FMR. LV remodeling for any given LV volume may have different local effects and result in different tenting and FMR.7 8 For example, in the present series, 2 patients with similar EDVI (202 and 206 mL/m2) and EF (30% and 23%) had very dissimilar apical (7.9 versus 6.4 cm) and posterior (3.5 versus 2.9 cm) displacements of papillary muscle, resulting in widely different tenting areas (8.3 versus 7.7 cm2) and ERO (34 versus 18 mm2). Therefore, local LV remodeling, although related to global LV changes, is the strongest independent determinant of FMR degree and explains its wide range. Lower blood pressure may also contribute to larger ERO through decreased coaptation pressure.35
Clinical Implications
That FMR may improve with treatment is well known,19
but recent data demonstrated that the main mechanism of improvement is
a reduction of ERO.36 The mechanisms of action of medical
treatment and the patients benefiting most from
treatment28 have not been defined, underscoring the
importance of analyzing FMR and local LV remodeling in future
trials.
In the future, surgical correction of apical and posterior displacements of papillary muscles to minimize tenting should probably be combined with annuloplasty30 and may provide rational approaches to FMR.
Study Limitations
Doppler methods used to quantify FMR may be criticized. In the
present study, 2 methods were combined; these methods have been
validated11 12 and confirmed by our
institution.13 21 Additionally, the accuracy of stroke
volume in patients without regurgitation and excellent
correlations with the proximal isovelocity surface area method confirm
that the methods used are not a limitation.
For the assessment of LV remodeling, high-resolution imaging allows accurate measurements. For local remodeling, the measures were obtained from appropriately oriented 2D views, with the use of well-defined accepted landmarks,7 10 and demonstrated high reproducibility.
Conclusions
FMR is a frequent complication of LVD but displays a wide range of
degree. Higher ERO of FMR is associated with the loss of annular
function and most strongly with excess mitral valvular tenting,
which is determined by the degree of local LV remodeling (apical and
posterior displacement of papillary muscle), independent of global LV
remodeling. These new quantitative observations should help define new
approaches to FMR complicating LVD.
| Footnotes |
|---|
Received September 21, 1999; revision received April 13, 2000; accepted April 22, 2000.
| References |
|---|
|
|
|---|
2. Desjardins VA, Enriquez-Sarano M, Tajik AJ, et al. Intensity of murmurs correlates with severity of valvular regurgitation. Am J Med. 1996;100:149156.[Medline] [Order article via Infotrieve]
3.
Rihal CS, Nishimura RA, Hatle LK, et al.
Systolic and diastolic dysfunction in patients with
clinical diagnosis of dilated cardiomyopathy:
relation to symptoms and prognosis. Circulation. 1994;90:27722779.
4. Pozzoli M, Capomolla S, Pinna G, et al. Doppler echocardiography reliably predicts pulmonary artery wedge pressure in patients with chronic heart failure with and without mitral regurgitation. J Am Coll Cardiol. 1996;27:883893.[Abstract]
5. Enriquez-Sarano M, Rossi A, Seward JB, et al. Determinants of pulmonary hypertension in left ventricular dysfunction. J Am Coll Cardiol. 1997;29:153159.[Abstract]
6.
Godley RW, Wann LS, Rogers EW, et al. Incomplete
mitral leaflet closure in patients with papillary muscle dysfunction.
Circulation. 1981;63:565571.
7.
Gorman RC, McCaughan JS, Ratcliffe MB, et al.
Pathogenesis of acute ischemic mitral
regurgitation in three dimensions. J Thorac
Cardiovasc Surg. 1995;109:684693.
8.
Otsuji Y, Handschumacher MD, Schwammenthal E, et al.
Insights from three-dimensional echocardiography
into the mechanism of functional mitral regurgitation:
direct in vivo demonstration of altered leaflet tethering geometry.
Circulation. 1997;96:19992008.
9. Dickerman SA, Rubler S. Mitral and tricuspid valve regurgitation in dilated cardiomyopathy. Am J Cardiol. 1989;63:629631.[Medline] [Order article via Infotrieve]
10.
Boltwood CM, Tei C, Wong M, et al. Quantitative
echocardiography of the mitral complex in dilated
cardiomyopathy: the mechanism of functional mitral
regurgitation. Circulation. 1983;68:498508.
11. Rokey R, Sterling LL, Zoghbi WA, et al. Determination of regurgitant fraction in isolated mitral or aortic regurgitation by pulsed Doppler two-dimensional echocardiography. J Am Coll Cardiol. 1986;7:12731278.[Abstract]
12.
Blumlein S, Bouchard A, Schiller NB, et al.
Quantitation of mitral regurgitation by Doppler
echocardiography. Circulation. 1986;74:306314.
13.
Enriquez-Sarano M, Bailey KR, Seward JB, et al.
Quantitative Doppler assessment of valvular
regurgitation. Circulation. 1993;87:841848.
14. American Society of Echocardiography Committee on Standards Subcommittee on Quantitation of Two-Dimensional Echocardiograms. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr. 1989;2:358367.[Medline] [Order article via Infotrieve]
15. DCruz IA, Shroff SG, Janicki JS, et al. Differences in the shape of the normal, cardiomyopathic, and volume overloaded human left ventricle. J Am Soc Echocardiogr. 1989;2:408414.[Medline] [Order article via Infotrieve]
16.
Sandler H, Dodge H. Left ventricular
tension and stress in man. Circ Res. 1963;13:91104.
17. Junker A, Thayssen P, Nielsen B, et al. The hemodynamic and prognostic significance of echo-Doppler-proven mitral regurgitation in patients with dilated cardiomyopathy. Cardiology. 1993;83:1420.[Medline] [Order article via Infotrieve]
18. McCully RB, Enriquez-Sarano M, Tajik AJ, et al. Overestimation of severity of ischemic/functional mitral regurgitation by color Doppler jet area. Am J Cardiol. 1994;74:790793.[Medline] [Order article via Infotrieve]
19. Hamilton MA, Stevenson LW, Child JS, et al. Sustained reduction in valvular regurgitation and atrial volumes with tailored vasodilator therapy in advanced congestive heart failure secondary to dilated (ischemic or idiopathic) cardiomyopathy. Am J Cardiol. 1991;67:259263.[Medline] [Order article via Infotrieve]
20. Hickey MS, Smith LR, Muhlbaier LH, et al. Current prognosis of ischemic mitral regurgitation. Implications for future management. Circulation. 1988;78(suppl I):I-51I-59.
21. Enriquez-Sarano M, Seward JB, Bailey KR, et al. Effective regurgitant orifice area: a noninvasive Doppler development of an old hemodynamic concept. J Am Coll Cardiol. 1994;23:443451.[Abstract]
22. Enriquez-Sarano M, Miller FAJ, Hayes SN, et al. Effective mitral regurgitant orifice area: clinical use and pitfalls of the proximal isovelocity surface area method. J Am Coll Cardiol. 1995;25:703709.[Abstract]
23.
Rozich JD, Carabello BA, Usher BW, et al. Mitral valve
replacement with and without chordal preservation in patients with
chronic mitral regurgitation: mechanisms for
differences in postoperative ejection performance.
Circulation. 1992;86:17181726.
24. Kono T, Sabbah HN, Rosman H, et al. Mechanism of functional mitral regurgitation during acute myocardial ischemia. J Am Coll Cardiol. 1992;19:11011105.[Abstract]
25. Blondheim DS, Jacobs LE, Kotler MN, et al. Dilated cardiomyopathy with mitral regurgitation: decreased survival despite a low frequency of left ventricular thrombus. Am Heart J. 1991;122:763771.[Medline] [Order article via Infotrieve]
26.
Lamas GA, Mitchell GF, Flaker GC, et al. Clinical
significance of mitral regurgitation after acute
myocardial infarction. Circulation. 1997;96:827833.
27.
Keren G, Katz S, Strom J, et al. Dynamic mitral
regurgitation: an important determinant of the
hemodynamic response to load alterations and inotropic
therapy in severe heart failure. Circulation. 1989;80:306313.
28. Evangelista-Masip A, Bruguera-Cortada J, Serrat-Serradell R, et al. Influence of mitral regurgitation on the response to captopril therapy for congestive heart failure caused by idiopathic dilated cardiomyopathy. Am J Cardiol. 1992;69:373376.[Medline] [Order article via Infotrieve]
29. Rankin JS, Hickey MS, Smith LR, et al. Ischemic mitral regurgitation. Circulation. 1989;79(suppl I):I-116I-121.
30.
Bolling SF, Deeb GM, Brunsting LA, et al. Early outcome
of mitral valve reconstruction in patients with end-stage
cardiomyopathy. J Thorac Cardiovasc
Surg. 1995;109:676683.
31.
Howard RJ, Moe GW, Armstrong PW. Sequential
echocardiographic-Doppler assessment of left
ventricular remodelling and mitral
regurgitation during evolving experimental heart
failure. Cardiovasc Res. 1991;25:468474.
32.
Perloff JK, Roberts WC. The mitral
apparatus: functional anatomy of mitral
regurgitation. Circulation. 1972;46:227239.
33. Kono T, Sabbah HN, Stein PD, et al. Left ventricular shape as a determinant of functional mitral regurgitation in patients with severe heart failure secondary to either coronary artery disease or idiopathic dilated cardiomyopathy. Am J Cardiol. 1991;68:355359.[Medline] [Order article via Infotrieve]
34. Kono T, Sabbah HN, Rosman H, et al. Left ventricular shape is the primary determinant of functional mitral regurgitation in heart failure. J Am Coll Cardiol. 1992;20:15941598.[Abstract]
35.
He S, Fontaine AA, Schwammenthal E, et al. Integrated
mechanism for functional mitral regurgitation: leaflet
restriction versus coapting force: in vitro studies.
Circulation. 1997;96:18261834.
36.
Rosario LB, Stevenson LW, Solomon SD, et al. The
mechanism of decrease in dynamic mitral regurgitation
during heart failure treatment: importance of reduction in the
regurgitant orifice size. J Am Coll Cardiol. 1998;32:18191824.
This article has been cited by other articles:
![]() |
E. Picano, P. Pibarot, P. Lancellotti, J. L. Monin, and R. O. Bonow The emerging role of exercise testing and stress echocardiography in valvular heart disease. J. Am. Coll. Cardiol., December 8, 2009; 54(24): 2251 - 2260. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Cabrera-Bueno, M. J. Molina-Mora, J. Alzueta, J. Pena-Hernandez, M. Jimenez-Navarro, J. Fernandez-Pastor, A. Barrera, and E. de Teresa Persistence of secondary mitral regurgitation and response to cardiac resynchronization therapy Eur J Echocardiogr, November 24, 2009; (2009) jep184v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Bhatt, C. E. Alfonso, A. M. Bhatt, S. Lee, A. C. Ferreira, T. A. Salerno, and E. de Marchena Effects and mechanisms of left ventricular false tendons on functional mitral regurgitation in patients with severe cardiomyopathy J. Thorac. Cardiovasc. Surg., November 1, 2009; 138(5): 1123 - 1128. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Penicka, H. Linkova, O. Lang, R. Fojt, V. Kocka, M. Vanderheyden, and J. Bartunek Predictors of Improvement of Unrepaired Moderate Ischemic Mitral Regurgitation in Patients Undergoing Elective Isolated Coronary Artery Bypass Graft Surgery Circulation, October 13, 2009; 120(15): 1474 - 1481. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Suri, J. Grewal, S. Mankad, M. Enriquez-Sarano, F. A. Miller Jr, and H. V. Schaff Is the anterior intertrigonal distance increased in patients with mitral regurgitation due to leaflet prolapse? Ann. Thorac. Surg., October 1, 2009; 88(4): 1202 - 1208. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. V. Badiwala, S. Verma, and V. Rao Surgical Management of Ischemic Mitral Regurgitation Circulation, September 29, 2009; 120(13): 1287 - 1293. [Full Text] [PDF] |
||||
![]() |
F. Langer, T. Kunihara, K. Hell, R. Schramm, K. I. Schmidt, D. Aicher, M. Kindermann, and H.-J. Schafers RING+STRING: Successful Repair Technique for Ischemic Mitral Regurgitation With Severe Leaflet Tethering Circulation, September 15, 2009; 120(11_suppl_1): S85 - S91. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Jensen, M. O. Jensen, M. H. Smerup, S. Vind-Kezunovic, S. Ringgaard, N. T. Andersen, R. Vestergaard, P. Wierup, J. M. Hasenkam, and S. L. Nielsen Impact of Papillary Muscle Relocation as Adjunct Procedure to Mitral Ring Annuloplasty in Functional Ischemic Mitral Regurgitation Circulation, September 15, 2009; 120(11_suppl_1): S92 - S98. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Chaput, M. D. Handschumacher, J. L. Guerrero, G. Holmvang, J. P. Dal-Bianco, S. Sullivan, G. J. Vlahakes, J. Hung, R. A. Levine, and for the Leducq Foundation MITRAL Transatlantic Net Mitral Leaflet Adaptation to Ventricular Remodeling: Prospective Changes in a Model of Ischemic Mitral Regurgitation Circulation, September 15, 2009; 120(11_suppl_1): S99 - S103. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Rubino, F. Onorati, G. Santarpino, E. Pasceri, G. Santarpia, L. Cristodoro, G. F. Serraino, and A. Renzulli Neurohormonal and echocardiographic results after CorCap and mitral annuloplasty for dilated cardiomyopathy. Ann. Thorac. Surg., September 1, 2009; 88(3): 719 - 725. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Onorati, A. S. Rubino, D. Marturano, E. Pasceri, G. Santarpino, S. Zinzi, G. Mascaro, and A. Renzulli Midterm clinical and echocardiographic results and predictors of mitral regurgitation recurrence following restrictive annuloplasty for ischemic cardiomyopathy J. Thorac. Cardiovasc. Surg., September 1, 2009; 138(3): 654 - 662. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-H. Kim, O. Kocaturk, C. Ozturk, A. Z. Faranesh, M. Sonmez, S. Sampath, C. E. Saikus, A. H. Kim, V. K. Raman, J. A. Derbyshire, et al. Mitral cerclage annuloplasty, a novel transcatheter treatment for secondary mitral valve regurgitation: initial results in swine. J. Am. Coll. Cardiol., August 11, 2009; 54(7): 638 - 651. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Dal-Bianco, E. Aikawa, J. Bischoff, J. L. Guerrero, M. D. Handschumacher, S. Sullivan, B. Johnson, J. S. Titus, Y. Iwamoto, J. Wylie-Sears, et al. Active Adaptation of the Tethered Mitral Valve: Insights Into a Compensatory Mechanism for Functional Mitral Regurgitation Circulation, July 28, 2009; 120(4): 334 - 342. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Maurer Mitral Leaflet in Functional Regurgitation: Passive Bystander or Active Player? Circulation, July 28, 2009; 120(4): 275 - 277. [Full Text] [PDF] |
||||
![]() |
R. M. Bolman III Have We Found the Surgical Solution for Ischemic Mitral Regurgitation? Circulation, June 2, 2009; 119(21): 2755 - 2757. [Full Text] [PDF] |
||||
![]() |
A. P.-W. Lee, M. Acker, S. H. Kubo, S. F. Bolling, S. W. Park, C. J. Bruce, and J. K. Oh Mechanisms of Recurrent Functional Mitral Regurgitation After Mitral Valve Repair in Nonischemic Dilated Cardiomyopathy: Importance of Distal Anterior Leaflet Tethering Circulation, May 19, 2009; 119(19): 2606 - 2614. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Delgado, L. F. Tops, J. D. Schuijf, A. de Roos, J. Brugada, M. J. Schalij, J. D. Thomas, and J. J. Bax Assessment of mitral valve anatomy and geometry with multislice computed tomography. J. Am. Coll. Cardiol. Img., May 1, 2009; 2(5): 556 - 565. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Flynn, R. Curtin, E. R. Nowicki, J. Rajeswaran, S. D. Flamm, E. H. Blackstone, and T. Mihaljevic Regional wall motion abnormalities and scarring in severe functional ischemic mitral regurgitation: A pilot cardiovascular magnetic resonance imaging study. J. Thorac. Cardiovasc. Surg., May 1, 2009; 137(5): 1063 - 70.e2. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Quill, A. J. Hill, T. G. Laske, O. Alfieri, and P. A. Iaizzo Mitral leaflet anatomy revisited. J. Thorac. Cardiovasc. Surg., May 1, 2009; 137(5): 1077 - 1081. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Armen, R. Vandse, J. A. Crestanello, S. V. Raman, K. M. Bickle, and N. S. Nathan Mechanisms of valve competency after mitral valve annuloplasty for ischaemic mitral regurgitation using the Geoform ring: insights from three-dimensional echocardiography Eur J Echocardiogr, January 1, 2009; 10(1): 74 - 81. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Donal, C. De Place, G. Kervio, F. Bauer, R. Gervais, C. Leclercq, P. Mabo, and J.-C. Daubert Mitral regurgitation in dilated cardiomyopathy: value of both regional left ventricular contractility and dyssynchrony Eur J Echocardiogr, January 1, 2009; 10(1): 133 - 138. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Sorajja, R. A. Nishimura, J. Thompson, and K. Zehr A Novel Method of Percutaneous Mitral Valve Repair for Ischemic Mitral Regurgitation J. Am. Coll. Cardiol. Intv., December 1, 2008; 1(6): 663 - 672. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. I. Parthenakis, A. P. Patrianakos, E. N. Simantirakis, and P. E. Vardas CRT and exercise capacity in heart failure: the impact of mitral valve regurgitation Europace, November 1, 2008; 10(suppl_3): iii96 - iii100. [Abstract] [Full Text] [PDF] |
||||
![]() |
2006 WRITING COMMITTEE MEMBERS, R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, et al. 2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons Circulation, October 7, 2008; 118(15): e523 - e661. [Full Text] [PDF] |
||||
![]() |
R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al. 2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons J. Am. Coll. Cardiol., September 23, 2008; 52(13): e1 - e142. [Full Text] [PDF] |
||||
![]() |
R. B. Prucz, E. S. Weiss, N. D. Patel, L. U. Nwakanma, A. S. Shah, and J. V. Conte The Impact of Surgical Ventricular Restoration on Mitral Valve Regurgitation Ann. Thorac. Surg., September 1, 2008; 86(3): 726 - 734. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. B. Prucz, E. S. Weiss, N. D. Patel, L. U. Nwakanma, W. A. Baumgartner, and J. V. Conte Coronary Artery Bypass Grafting With or Without Surgical Ventricular Restoration: A Comparison Ann. Thorac. Surg., September 1, 2008; 86(3): 806 - 814. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. D. Gillam Is It Time to Update the Definition of Functional Mitral Regurgitation?: Structural Changes in the Mitral Leaflets With Left Ventricular Dysfunction Circulation, August 19, 2008; 118(8): 797 - 799. [Full Text] [PDF] |
||||
![]() |
M. Chaput, M. D. Handschumacher, F. Tournoux, L. Hua, J. L. Guerrero, G. J. Vlahakes, and R. A. Levine Mitral Leaflet Adaptation to Ventricular Remodeling: Occurrence and Adequacy in Patients With Functional Mitral Regurgitation Circulation, August 19, 2008; 118(8): 845 - 852. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Calafiore, A. L. Iaco, M. Contini, A. Bivona, E. Varone, P. Greco, and S. Scandura Mitral Valve Repair for Ischemic Mitral Regurgitation Angiology, August 1, 2008; 59(2_suppl): 89S - 92S. [Abstract] [PDF] |
||||
![]() |
J-M Song, M-J Kim, Y-J Kim, S-H Kang, J-J Kim, D-H Kang, and J-K Song Three-dimensional characteristics of functional mitral regurgitation in patients with severe left ventricular dysfunction: a real-time three-dimensional colour Doppler echocardiography study Heart, May 1, 2008; 94(5): 590 - 596. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gelsomino, R. Lorusso, I. Capecchi, C. Rostagno, S. Romagnoli, G. Bille, G. De Cicco, C. Tetta, P. Stefano, and G. F. Gensini Left Ventricular Reverse Remodeling After Undersized Mitral Ring Annuloplasty in Patients With Ischemic Regurgitation Ann. Thorac. Surg., April 1, 2008; 85(4): 1319 - 1330. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ypenburg, P. Lancellotti, L. F. Tops, E. Boersma, G. B. Bleeker, E. R. Holman, J. D. Thomas, M. J. Schalij, L. A. Pierard, and J. J. Bax Mechanism of improvement in mitral regurgitation after cardiac resynchronization therapy Eur. Heart J., March 2, 2008; 29(6): 757 - 765. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. De Bonis, E. Lapenna, A. Verzini, G. La Canna, A. Grimaldi, L. Torracca, F. Maisano, and O. Alfieri Recurrence of Mitral Regurgitation Parallels the Absence of Left Ventricular Reverse Remodeling After Mitral Repair in Advanced Dilated Cardiomyopathy Ann. Thorac. Surg., March 1, 2008; 85(3): 932 - 939. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Agricola, M. Oppizzi, M. Pisani, A. Meris, F. Maisano, and A. Margonato Ischemic mitral regurgitation: mechanisms and echocardiographic classification Eur J Echocardiogr, March 1, 2008; 9(2): 207 - 221. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Enriquez-Sarano, D. F. Loulmet, and D. Burkhoff The conundrum of functional mitral regurgitation in chronic heart failure. J. Am. Coll. Cardiol., January 29, 2008; 51(4): 487 - 489. [Full Text] [PDF] |
||||
![]() |
S. Gelsomino, R. Lorusso, G. De Cicco, I. Capecchi, C. Rostagno, S. Caciolli, S. Romagnoli, U. Da Broi, P. Stefano, and G. F. Gensini Five-year echocardiographic results of combined undersized mitral ring annuloplasty and coronary artery bypass grafting for chronic ischaemic mitral regurgitation Eur. Heart J., January 2, 2008; 29(2): 231 - 240. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Enriquez-Sarano, V. T. Nkomo, and H. Michelena Principles and Practice of Echocardiography in Cardiac Surgery Card. Surg. Adult, January 1, 2008; 3(2008): 315 - 348. [Full Text] |
||||
![]() |
W. Y. Szeto, R. C. Gorman, J. H. Gorman III, and M. A. Acker Ischemic Mitral Regurgitation Card. Surg. Adult, January 1, 2008; 3(2008): 785 - 802. [Full Text] |
||||
![]() |
J. I. Fann, N. B. Ingels Jr., and D. C. Miller Pathophysiology of Mitral Valve Disease Card. Surg. Adult, January 1, 2008; 3(2008): 973 - 1012. [Full Text] |
||||
![]() |
P. Lancellotti, E. Donal, B. Cosyns, G. Van Camp, J.-L. Monin, E. Brochet, A. Berrebi, P. Pibarot, C. Chauvel, C. Hassager, et al. Effects of surgery on ischaemic mitral regurgitation: a prospective multicentre registry (SIMRAM registry) Eur J Echocardiogr, January 1, 2008; 9(1): 26 - 30. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Di Donato, S. Castelvecchio, J. Brankovic, C. Santambrogio, V. Montericcio, and L. Menicanti Effectiveness of surgical ventricular restoration in patients with dilated ischemic cardiomyopathy and unrepaired mild mitral regurgitation. J. Thorac. Cardiovasc. Surg., December 1, 2007; 134(6): 1548 - 1553. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Perez de Isla, J. Zamorano, M. Quezada, C. Almeria, J. L. Rodrigo, V. Serra, J. C. Garcia Rubira, A. F. Ortiz, and C. Macaya Functional mitral regurgitation after a first non-ST-segment elevation acute coronary syndrome: contribution to congestive heart failure Eur. Heart J., December 1, 2007; 28(23): 2866 - 2872. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-C. Corvol, J.-B. Anzouan-Kacou, E. Fauveau, A.-M. Bonnet, B. Lebrun-Vignes, C. Girault, Y. Agid, P. Lechat, R. Isnard, and L. Lacomblez Heart Valve Regurgitation, Pergolide Use, and Parkinson Disease: An Observational Study and Meta-analysis Arch Neurol, December 1, 2007; 64(12): 1721 - 1726. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Hung, M. Chaput, J. L. Guerrero, M. D. Handschumacher, L. Papakostas, S. Sullivan, J. Solis, and R. A. Levine Persistent Reduction of Ischemic Mitral Regurgitation by Papillary Muscle Repositioning: Structural Stabilization of the Papillary Muscle Ventricular Wall Complex Circulation, September 11, 2007; 116(11_suppl): I-259 - I-263. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Roshanali, M. H. Mandegar, M. A. Yousefnia, H. Rayatzadeh, and F. Alaeddini A Prospective Study of Predicting Factors in Ischemic Mitral Regurgitation Recurrence After Ring Annuloplasty Ann. Thorac. Surg., September 1, 2007; 84(3): 745 - 749. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Madaric, M. Vanderheyden, C. Van Laethem, K. Verhamme, A. Feys, M. Goethals, S. Verstreken, P. Geelen, M. Penicka, B. De Bruyne, et al. Early and late effects of cardiac resynchronization therapy on exercise-induced mitral regurgitation: relationship with left ventricular dyssynchrony, remodelling and cardiopulmonary performance Eur. Heart J., September 1, 2007; 28(17): 2134 - 2141. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Chumnanvej, M. J. Wood, T. E. MacGillivray, and M. F. V. Melo Perioperative Echocardiographic Examination for Ventricular Assist Device Implantation Anesth. Analg., September 1, 2007; 105(3): 583 - 601. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kwan, M. A. Gillinov, J. D. Thomas, and T. Shiota Geometric predictor of significant mitral regurgitation in patients with severe ischemic cardiomyopathy, undergoing Dor procedure: A real-time 3D echocardiographic study Eur J Echocardiogr, June 1, 2007; 8(3): 195 - 203. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D'Andrea, P. Caso, S. Cuomo, R. Scarafile, G. Salerno, G. Limongelli, G. Di Salvo, S. Severino, L. Ascione, P. Calabro, et al. Effect of dynamic myocardial dyssynchrony on mitral regurgitation during supine bicycle exercise stress echocardiography in patients with idiopathic dilated cardiomyopathy and 'narrow' QRS Eur. Heart J., April 2, 2007; 28(8): 1004 - 1011. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fukuoka, M. Nonaka, S. Masuyama, T. Shimamoto, K. Tambara, H. Yoshida, T. Ikeda, and M. Komeda Chordal "translocation" for functional mitral regurgitation with severe valve tenting: An effort to preserve left ventricular structure and function J. Thorac. Cardiovasc. Surg., April 1, 2007; 133(4): 1004 - 1011. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.K. Oh Echocardiography in heart failure: Beyond diagnosis Eur J Echocardiogr, January 1, 2007; 8(1): 4 - 14. [Full Text] [PDF] |
||||
![]() |
G. Barletta, A. Toso, R. Del Bene, M. Di Donato, M. Sabatier, and V. Dor Preoperative and Late Postoperative Mitral Regurgitation in Ventricular Reconstruction: Role of Local Left Ventricular Deformation Ann. Thorac. Surg., December 1, 2006; 82(6): 2102 - 2109. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Aronson, N. Goldsher, R. Zukermann, M. Kapeliovich, J. Lessick, D. Mutlak, S. Dabbah, W. Markiewicz, R. Beyar, H. Hammerman, et al. Ischemic Mitral Regurgitation and Risk of Heart Failure After Myocardial Infarction Arch Intern Med, November 27, 2006; 166(21): 2362 - 2368. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Perez de Isla, J. Zamorano, M. Quezada, C. Almeria, J. L. Rodrigo, V. Serra, J. C. Garcia Rubira, A. F. Ortiz, and C. Macaya Prognostic significance of functional mitral regurgitation after a first non-ST-segment elevation acute coronary syndrome Eur. Heart J., November 2, 2006; 27(22): 2655 - 2660. [Abstract] [Full Text] [PDF] |
||||
![]() |
E Agricola, M Oppizzi, M Galderisi, M Pisani, A Meris, C Pappone, and A Margonato Role of regional mechanical dyssynchrony as a determinant of functional mitral regurgitation in patients with left ventricular systolic dysfunction Heart, October 1, 2006; 92(10): 1390 - 1395. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Acker, S. Bolling, R. Shemin, J. Kirklin, J. K. Oh, D. L. Mann, M. Jessup, H. N. Sabbah, R. C. Starling, S. H. Kubo, et al. Mitral valve surgery in heart failure: Insights from the Acorn Clinical Trial. J. Thorac. Cardiovasc. Surg., September 1, 2006; 132(3): 568 - 577.e4. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al. ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Developed in Collaboration With the Society of Cardiovascular Anesthesiologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons J. Am. Coll. Cardiol., August 1, 2006; 48(3): e1 - e148. [Full Text] [PDF] |
||||
![]() |
R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al. ACC/AHA 2006 Practice Guidelines for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Developed in Collaboration With the Society of Cardiovascular Anesthesiologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons J. Am. Coll. Cardiol., August 1, 2006; 48(3): 598 - 675. [Full Text] [PDF] |
||||
![]() |
P-V Ennezat, B Gal, C Kouakam, C Marquie, T LeTourneau, D Klug, D Lacroix, D Logeart, A Cohen-Solal, S Dennetiere, et al. Cardiac resynchronisation therapy reduces functional mitral regurgitation during dynamic exercise in patients with chronic heart failure: an acute echocardiographic study Heart, August 1, 2006; 92(8): 1091 - 1095. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Timek, D. T. Lai, P. Dagum, D. Liang, G. T. Daughters, N. B. Ingels Jr, and D. C. Miller Mitral Leaflet Remodeling in Dilated Cardiomyopathy Circulation, July 4, 2006; 114(1_suppl): I-518 - I-523. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Kuwahara, Y. Otsuji, Y. Iguro, T. Ueno, F. Zhu, N. Mizukami, K. Kubota, K. Nakashiki, T. Yuasa, B. Yu, et al. Mechanism of Recurrent/Persistent Ischemic/Functional Mitral Regurgitation in the Chronic Phase After Surgical Annuloplasty: Importance of Augmented Posterior Leaflet Tethering Circulation, July 4, 2006; 114(1_suppl): I-529 - I-534. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Daimon, S. Fukuda, D. H. Adams, P. M. McCarthy, A. M. Gillinov, A. Carpentier, F. Filsoufi, V. M. Abascal, V. H. Rigolin, S. Salzberg, et al. Mitral Valve Repair With Carpentier-McCarthy-Adams IMR ETlogix Annuloplasty Ring for Ischemic Mitral Regurgitation: Early Echocardiographic Results From a Multi-Center Study Circulation, July 4, 2006; 114(1_suppl): I-588 - I-593. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Messas, A. Bel, M. C. Morichetti, C. Carrion, M. D. Handschumacher, S. Peyrard, J. T. Vilquin, M. Desnos, P. Bruneval, A. Carpentier, et al. Autologous Myoblast Transplantation for Chronic Ischemic Mitral Regurgitation J. Am. Coll. Cardiol., May 16, 2006; 47(10): 2086 - 2093. [Abstract] [Full Text] [PDF] |
||||
![]() |
E.A. Grossi, Y.J. Woo, C.F. Schwartz, D.M. Gangahar, V.A. Subramanian, N. Patel, J. Wudel, P.L. DiGiorgi, A. Singh, and R.D. Davis Comparison of Coapsys annuloplasty and internal reduction mitral annuloplasty in the randomized treatment of functional ischemic mitral regurgitation: Impact on the left ventricle J. Thorac. Cardiovasc. Surg., May 1, 2006; 131(5): 1095 - 1098. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. V. Ennezat, S. Marechaux, T. Le Tourneau, N. Lamblin, C. Bauters, E. Van Belle, B. Gal, S. Kacet, P. Asseman, G. Deklunder, et al. Myocardial asynchronism is a determinant of changes in functional mitral regurgitation severity during dynamic exercise in patients with chronic heart failure due to severe left ventricular systolic dysfunction Eur. Heart J., March 2, 2006; 27(6): 679 - 683. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. De Simone, I. Wolf, S. Mottl-Link, R. Hoda, B. Mikhail, F.-U. Sack, H.-P. Meinzer, and S. Hagl A clinical study of annular geometry and dynamics in patients with ischemic mitral regurgitation: new insights into asymmetrical ring annuloplasty Eur. J. Cardiothorac. Surg., March 1, 2006; 29(3): 355 - 361. [Abstract] [Full Text] [PDF] |
||||
![]() |
Is a good perioperative echocardiographic result predictive of durability in ischemic mitral valve repair? J. Thorac. Cardiovasc. Surg., March 1, 2006; 131(3): 565 - 573.e2. |
||||
![]() |
M. A. Borger, A. Alam, P. M. Murphy, T. Doenst, and T. E. David Chronic Ischemic Mitral Regurgitation: Repair, Replace or Rethink? Ann. Thorac. Surg., March 1, 2006; 81(3): 1153 - 1161. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. R. Brandt, C. Reiner, R. Arnold, J. Sperzel, H. F. Pitschner, and C. W. Hamm Contractile response and mitral regurgitation after temporary interruption of long-term cardiac resynchronization therapy Eur. Heart J., January 2, 2006; 27(2): 187 - 192. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Porciani, R. Macioce, G. Demarchi, M. Chiostri, N. Musilli, F. Cappelli, A. Lilli, G. Ricciardi, and L. Padeletti Effects of cardiac resynchronization therapy on the mechanisms underlying functional mitral regurgitation in congestive heart failure Eur J Echocardiogr, January 1, 2006; 7(1): 31 - 39. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Bax, T. Abraham, S. S. Barold, O. A. Breithardt, J. W.H. Fung, S. Garrigue, J. Gorcsan III, D. L. Hayes, D. A. Kass, J. Knuuti, et al. Cardiac Resynchronization Therapy: Part 2--Issues During and After Device Implantation and Unresolved Questions J. Am. Coll. Cardiol., December 20, 2005; 46(12): 2168 - 2182. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Fukuda, R. Grimm, J.-M. Song, T. Kihara, M. Daimon, D. A. Agler, B. L. Wilkoff, A. Natale, J. D. Thomas, and T. Shiota Electrical Conduction Disturbance Effects on Dynamic Changes of Functional Mitral Regurgitation J. Am. Coll. Cardiol., December 20, 2005; 46(12): 2270 - 2276. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Grossi, P. C. Saunders, Y. J. Woo, D. M. Gangahar, J. C. Laschinger, D. C. Kress, M. P. Caskey, C. F. Schwartz, and J. Wudel Intraoperative Effects of the Coapsys Annuloplasty System in a Randomized Evaluation (RESTOR-MV) of Functional Ischemic Mitral Regurgitation Ann. Thorac. Surg., November 1, 2005; 80(5): 1706 - 1711. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Giga, M. Ostojic, B. Vujisic-Tesic, A. Djordjevic-Dikic, J. Stepanovic, B. Beleslin, M. Petrovic, M. Nedeljkovic, I. Nedeljkovic, and N. Milic Exercise-induced changes in mitral regurgitation in patients with prior myocardial infarction and left ventricular dysfunction: relation to mitral deformation and left ventricular function and shape Eur. Heart J., September 2, 2005; 26(18): 1860 - 1865. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-Y. Yu, M.-Y. Su, Y.-S. Chen, F.-Y. Lin, and W.-Y. I. Tseng Mitral tetrahedron as a geometrical surrogate for chronic ischemic mitral regurgitation Am J Physiol Heart Circ Physiol, September 1, 2005; 289(3): H1218 - H1225. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Langer, F. Rodriguez, S. Ortiz, A. Cheng, T. C. Nguyen, M. K. Zasio, D. Liang, G. T. Daughters, N. B. Ingels, and D. C. Miller Subvalvular Repair: The Key to Repairing Ischemic Mitral Regurgitation? Circulation, August 30, 2005; 112(9_suppl): I-383 - I-389. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Zhu, Y. Otsuji, G. Yotsumoto, T. Yuasa, T. Ueno, B. Yu, C. Koriyama, S. Hamasaki, S. Biro, A. Kisanuki, et al. Mechanism of Persistent Ischemic Mitral Regurgitation After Annuloplasty: Importance of Augmented Posterior Mitral Leaflet Tethering Circulation, August 30, 2005; 112(9_suppl): I-396 - I-401. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. De Bonis, E. Lapenna, G. La Canna, E. Ficarra, M. Pagliaro, L. Torracca, F. Maisano, and O. Alfieri Mitral Valve Repair for Functional Mitral Regurgitation in End-Stage Dilated Cardiomyopathy: Role of the "Edge-to-Edge" Technique Circulation, August 30, 2005; 112(9_suppl): I-402 - I-408. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Levine and E. Schwammenthal Ischemic Mitral Regurgitation on the Threshold of a Solution: From Paradoxes to Unifying Concepts Circulation, August 2, 2005; 112(5): 745 - 758. [Full Text] [PDF] |
||||
![]() |
T. Uemura, Y. Otsuji, K. Nakashiki, S. Yoshifuku, Y. Maki, B. Yu, N. Mizukami, E. Kuwahara, S. Hamasaki, S. Biro, et al. Papillary Muscle Dysfunction Attenuates Ischemic Mitral Regurgitation in Patients With Localized Basal Inferior Left Ventricular Remodeling: Insights From Tissue Doppler Strain Imaging J. Am. Coll. Cardiol., July 5, 2005; 46(1): 113 - 119. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Srichai, R. A. Grimm, A. E. Stillman, A. M. Gillinov, L. L. Rodriguez, M. L. Lieber, A. Lara, J. A. Weaver, P. M. McCarthy, and R. D. White Ischemic Mitral Regurgitation: Impact of the Left Ventricle and Mitral Valve in Patients with Left Ventricular Systolic Dysfunction Ann. Thorac. Surg., July 1, 2005; 80(1): 170 - 178. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. A. Tibayan, F. Rodriguez, F. Langer, M. K. Zasio, L. Bailey, D. Liang, G. T. Daughters, N. B. Ingels Jr, and D. C. Miller Annular or subvalvular approach to chronic ischemic mitral regurgitation? J. Thorac. Cardiovasc. Surg., June 1, 2005; 129(6): 1266 - 1275. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Daimon, T. Shiota, A. M. Gillinov, M. Hayase, M. Ruel, W. E. Cohn, S. J. Blacker, and J. R. Liddicoat Percutaneous Mitral Valve Repair for Chronic Ischemic Mitral Regurgitation: A Real-Time Three-Dimensional Echocardiographic Study in an Ovine Model Circulation, May 3, 2005; 111(17): 2183 - 2189. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Braun, J. J. Bax, M. I.M. Versteegh, P. G. Voigt, E. R. Holman, R. J.M. Klautz, E. Boersma, and R. A.E. Dion Preoperative left ventricular dimensions predict reverse remodeling following restrictive mitral annuloplasty in ischemic mitral regurgitation Eur. J. Cardiothorac. Surg., May 1, 2005; 27(5): 847 - 853. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Menicanti and M. Di Donato Left ventricular aneurysm/reshaping techniques MMCTS, April 25, 2005; 2005(0425): 596. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Watanabe, Y. Ogasawara, Y. Yamaura, T. Kawamoto, E. Toyota, T. Akasaka, and K. Yoshida Quantitation of mitral valve tenting in ischemic mitral regurgitation by transthoracic real-time three-dimensional echocardiography J. Am. Coll. Cardiol., March 1, 2005; 45(5): 763 - 769. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. Wu, K. D. Aaronson, S. F. Bolling, F. D. Pagani, K. Welch, and T. M. Koelling Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction J. Am. Coll. Cardiol., February 1, 2005; 45(3): 381 - 387. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. V. Salukhe, M. Y. Henein, and R. Sutton Ischemic Mitral Regurgitation and Its Related Risk After Myocardial Infarction Circulation, January 25, 2005; 111(3): 254 - 256. [Full Text] [PDF] |
||||
![]() |
F. Bursi, M. Enriquez-Sarano, V. T. Nkomo, S. J. Jacobsen, S. A. Weston, R. A. Meverden, and V. L. Roger Heart Failure and Death After Myocardial Infarction in the Community: The Emerging Role of Mitral Regurgitation Circulation, January 25, 2005; 111(3): 295 - 301. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |